helpline 01494 601 400
enquiries 01494 601 300

board of trustees

Peter Worthington, chairman

Peter Worthington, new chairman of board of trustees at Epilepsy Society. Peter has grey hair and glasses and is smiling at the cameraPeter Worthington was appointed as chairman of the board of trustees in November 2017. He has worked in the international energy and natural resources sector and is the chief executive of a small African focused oil and gas start-up venture. Peter is also chairman of the Board of the London North West NHS Healthcare University Trust Board. His early career was spent in private and corporate commercial law in Australia.

Peter  came to London with his wife Sarah, a law academic at the University of Cambridge, and their four children in 1995 after living in Moscow for four years. He enjoys walking, swimming and playing golf as well as theatre, history, physics and following medical advances.

Adrian Waddingham

Adrian Waddingham was appointed to the board in 2012 and was interim chairman from 2016-2017. He was a founding partner of Barnett Waddingham, now the UK’s largest independent firm of consulting actuaries. Adrian was awarded the CBE in 2012 for services to the actuarial and pensions professions. Adrian remains a partner in Barnett Waddingham which has over 700 staff including in seven offices throughout the UK. Adrian is a past Chairman of the Association of Consulting Actuaries, and the International Association of Consulting Actuaries and served a s a Sheriff of the City of London from 2013 to 2014.

Adrian is a governor of the Pension Policy Institute and a trustee of the Skeletal Cancer Action Trust. He is also an ambassador of the Seeabilty Trust, and a Fellow of Royal Holloway College London University. Adrian lives in Gerrards Cross Buckinghamshire and also has a home in his native north Lancashire.

Chris Blue

Chris BlueChris Blue was elected to the board of trustees in 2014. He has worked for global multi-national corporations spanning the finance, information technology and automotive sectors where he has designed manufacturer network strategies, implemented European wide legislation and delivered award winning customer service.  

Chris now runs his own management consultancy company specialising in strategic planning, cultural alignment and people development. He lives in Princes Risborough with his wife and three children, the eldest of whom has had epilepsy since birth.  Chris is also a keen sportsman and enjoys an active and healthy lifestyle.

Peter Goodfellow

Peter joined the board of trustees as honorary treasurer in December 2014. He also chairs the finance and general purposes committee. Peter is chief financial officer of a listed Pan-Asia equity research firm and has a background in financial services.

He is an associate (ACA) of the Institute of Chartered Accountants in England and Wales; he has an MA in business management from Kingston Business School and a BSc from the University of Birmingham. Peter enjoys climbing and mountaineering, when family commitments allow, and keeps fit doing crossfit and the occasional triathlon.

Michael Kirilloff

Michael joined the board of trustees in January 2015 and is also a trustee of the Pensions Fund as well as a member of the Research and Life Sciences, Finance and General Purposes, Senior Appointments and Fundraising, Marketing and External Affairs committees.

He took early retirement from an international career at shell international Petroleum Co. Ltd to help support his son from the associated complications of autism and epilepsy. He and his family understand the terrible implications of caring and supporting a family member with epilepsy, especially as they have lost their son to SUDEP (sudden unexpected death in epilepsy).

Michael is fully committed to enabling the Society's world class research and medical team to achieve pioneering breakthroughs in understanding and clinically treating Epilepsy for the benefit of current and future generations. 

Dr Richard RobertsDr Richard Roberts

Richard Roberts joined the board as an additional trustee in November 2012. As a consultant neurologist, he has had special clinical and research interests in epilepsy and the provision of services for people with epilepsy. He was chairman of the development group for the SIGN guideline on Diagnosis and Management of Epilepsy in Adults (2003).

Deborah Wheeler

Deobrah WheelerDeborah Wheeler was appointed to the board in 2012 and trained as a nurse at St Bartholomew's Hospital, spending her clinical career in orthopaedic nursing before moving into nursing management.  She has been director of nursing at several NHS trusts in London over a period of 16 years.  In 2012 she moved to become deputy director of nursing (East) for NHS South of England and also works one day per week as director of education (Nursing & Midwifery) for UCL Partners. In April 2013 she took up a new post as regional head of quality aAssurance (South) for NHS England.

From 2002-2006 Deborah was chair of the Royal College of Nursing Society of Orthopaedic and Trauma Nursing. She was a member of the Church of England's Hospital Chaplaincy Council from 2000-2010 and was on the multi-faith group for healthcare chaplaincy from 2006-2010. Deborah has mentored nurses and was part of the Black and Minority Ethnic Leadership Programmes. Her youngest son has lived with epilepsy since he was eight years old.

Joe Brice

Joe Brice is Public Affairs Director for Region Europe at Shire plc.  Prior to this he was Patient and Innovation Policy Director for Northern Europe at Baxalta.   Joe has over twenty years’ experience as a leader in public affairs, devising and implementing successful integrated communications strategies.

Joe gained early experience of working within government, having started his career in the House of Commons as Research Assistant to Sebastian Coe, supporting his work as Parliamentary Private Secretary to the Deputy Prime Minister, Michael Heseltine.  He went on to work in the public affairs arms of global agencies, Saatchi & Saatchi and Edelman.

Moving into pharma, Joe was Head of Government & Industry Affairs at Schering Health Care, and then Head of Government Affairs & Advocacy at Bayer HealthCare.

Before joining Baxalta Joe also spent time as Head of Corporate Affairs & Brand at Bayer plc, responsible for corporate communications, issues management, government affairs and Corporate Social Responsibility programmes.

Kate Alcock   

Kate joined the Board of the Society in December 2015. She is an experienced Trustee with a long background in senior business management and political lobbying and was formerly the ViceChair of an HIV charity. A qualified Chartered Surveyor and HR Practitioner she has acted for many large charities and not for profit organisations over her career.  She is also an adviser with Citizens Advice where she meets many people with Epilepsy. 

A former member of the Derbyshire Police Authority, Kate chairs the Joint Audit Committee for the PCC and Chief Constable and manages a small family estate in Derbyshire. 

John Barradell   

John joined the Board in December 2015 and has had a long career both running marketing teams across Europe for major US computer companies and within the public sector. He has chaired a local community development trust and since 2002 has worked in local government, as Chief Executive at Brighton & Hove and currently as Town Clerk and Chief Executive of the City of London Corporation. 

He served for over 25 years as a volunteer police officer in London, for seven years of which he was the Chief Officer of the special constabulary in the Met Police. He was appointed OBE for services to policing in 2007. John was diagnosed with Temporal Lobe Epilepsy in 2014

Jim Hagan 

Jim was elected to the Board of Trustees in December 2015 and chairs the Life Sciences Committee. Following graduation he took a PhD in neuroscience and after postdoctoral research in the UK and The Netherland worked in leadership positions in the pharmaceutical industry, focusing on the discovery and development of drugs for psychiatric and neurological conditions. 

From 2009-2015 he led GMEC, a not-for-profit company formed by six leading UK universities to foster biomedical translational research. He is a non-executive director at Imanova, a research based biomedical imaging company, and is Senior Research Fellow in Neuroscience at Heptares Therapeutics. Scientific advances drive improvements in treatment and diagnosis in all medical conditions and he is motivated to improve the lives of those who live with epilepsy through the continued application of world class biomedical science.

Ian Pike 

Ian is currently Chief Operating Officer of Proteome Sciences. As Executive Director, Ian is responsible for management of all operational aspects of business including R&D, Business Development, Sales & Marketing and Intellectual Property. Ian has also been a Founding Board Member for South East Healthcare Technologies Alliance for seven years from 2005 to 2012.